SAS Output

21-AUG-2019 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 832 6 313 35 426 63 384
ERLYTX 149 12 626 46 560 63 384
GI 149 3 157 23 280 39 237
GU 688 20 1044 86 1047 146 889
LEUK 124 5 261 17 207 28 170
LUNG 180 5 261 23 280 37 225
LYMPH 49 0 0 4 49 9 55
MELAN 157 3 157 19 231 38 231
MMYEL 82 1 52 6 73 9 55
OTHER 30 1 52 3 37 5 30
SXQOL 9 1 52 1 12 1 6
Total 2449 57 2975 263 3202 438 2666

21-AUG-2019 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 481 9 470 48 584 95 578
CCD 1532 24 1252 107 1303 215 1309
GU 9 0 0 2 24 3 18
LUNG 769 19 991 112 1364 223 1358
OTHER 4 0 0 0 0 0 0
PREV 46 1 52 5 61 11 67
SURV 177 4 209 10 122 19 116
SXQOL 51 4 209 21 256 33 201
Total 3069 61 3183 305 3714 599 3647

21-AUG-2019 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1313 15 783 83 1011 158 962
CCD 1532 24 1252 107 1303 215 1309
ERLYTX 149 12 626 46 560 63 384
GI 149 3 157 23 280 39 237
GU 697 20 1044 88 1071 149 907
LEUK 124 5 261 17 207 28 170
LUNG 949 24 1252 135 1644 260 1583
LYMPH 49 0 0 4 49 9 55
MELAN 157 3 157 19 231 38 231
MMYEL 82 1 52 6 73 9 55
OTHER 34 1 52 3 37 5 30
PREV 46 1 52 5 61 11 67
SURV 177 4 209 10 122 19 116
SXQOL 60 5 261 22 268 34 207
Total 5518 118 6158 568 6917 1037 6313

21-AUG-2019 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 521 2 104 20 244 35 213
ERLYTX 106 7 365 27 329 41 250
GI 100 0 0 10 122 16 97
GU 481 16 835 63 767 107 651
LEUK 111 3 157 15 183 26 158
LUNG 164 4 209 18 219 32 195
LYMPH 36 0 0 2 24 6 37
MELAN 118 1 52 12 146 28 170
MMYEL 68 0 0 4 49 5 30
OTHER 30 1 52 3 37 5 30
SXQOL 9 1 52 1 12 1 6
Total 1744 35 1826 175 2132 302 1837

21-AUG-2019 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 479 7 365 46 560 93 566
CCD 1138 15 783 74 901 143 871
GU 9 0 0 2 24 3 18
LUNG 535 13 678 66 804 132 804
OTHER 4 0 0 0 0 0 0
PREV 33 0 0 2 24 6 37
SURV 124 3 157 9 110 17 103
SXQOL 50 4 209 21 256 32 195
Total 2372 42 2192 220 2679 426 2594

21-AUG-2019 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1032 16 835 68 828 131 797
CCD 1167 14 730 73 889 143 871
ERLYTX 106 7 365 27 329 41 250
GI 144 0 0 10 122 16 97
GU 490 16 835 65 791 110 670
LEUK 118 3 157 14 170 27 164
LUNG 699 17 887 84 1023 164 998
LYMPH 36 0 0 2 24 6 37
MELAN 118 1 52 12 146 28 170
MMYEL 68 0 0 4 49 5 30
OTHER 35 0 0 2 24 5 30
PREV 33 0 0 2 24 6 37
SURV 127 0 0 10 122 18 110
SXQOL 59 5 261 22 268 33 201
Total 4232 79 4122 395 4809 733 4462

21-AUG-2019 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 665 5 261 28 341 52 317
ERLYTX 106 11 574 43 524 57 347
GI 88 2 104 20 244 34 207
GU 588 17 887 70 852 124 755
LEUK 46 2 104 4 49 4 24
LUNG 88 3 157 18 219 29 177
LYMPH 25 0 0 3 37 5 30
MELAN 142 3 157 19 231 36 219
MMYEL 32 1 52 6 73 8 49
Total 1780 44 2296 211 2570 349 2125

21-AUG-2019 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1547 27 1409 162 1972 287 1747
AFFIL 198 7 365 29 353 37 225
CCOP/NCORP 2371 43 2244 204 2484 404 2459
Non-SWOG 1392 32 1670 163 1985 299 1820
Total 5508 109 5688 558 6794 1027 6251

21-AUG-2019 6:10

STUDIES CLOSED THIS MONTH

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK S1312 ALL, CD22+, REL/REF, Inotuzumab+CVP 1 N 02-AUG-19

21-AUG-2019 6:10

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Registrations
CCD S1415CD TrACER CSF Standing Order Intervention for FN 1 21
LUNG LUNGMAP NSCLC, Adv, Master 1 15
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 12
GU S1602 Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 12
ERLYTX S1609 Rare Tumor, Comb Nivo/Ipi 1 11
BREAST EA1151 Brst, Tomosynthesis Mammographic Screening 1 8
LUNG LUNGMAP NSCLC, Adv, Master 2 7
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 2 5
SURV S1501 Surv, Breast Stg IV, Card Tox w/ Carvedilol 2 4
LUNG A151216 ALCHEMIST0 - screening 1 3
LUNG A151216 ALCHEMIST0 - screening 0 3
LUNG LUNGMAP NSCLC, Adv, Master 0 3
LUNG S1400 SCCA,Adv, Biomarker Master 2 3
SXQOL S1714 CIPN Risk Prediction Cohort Study, Taxanes 1 3
MELAN S1801 Melan, Adv, Adj vs Neoadj Pembrolizumab 1 3
MELAN S1801 Melan, Adv, Adj vs Neoadj Pembrolizumab 2 3
GU S1802 Pros, Stg IV, SST +/- Surg/RT to Primary Tum 1 3